Hyon K Choi
Massachusetts General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hyon K Choi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:22 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07346079 · Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout FlaresMassachusetts General Hospital · recruiting · Gout Arthritis, Gout Flare, Gout · principal investigator
- Ph4NCT06674109 · SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) TrialMassachusetts General Hospital · recruiting · Gout and Hyperuricemia · principal investigator
- Ph4NCT04875702 · Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutMassachusetts General Hospital · recruiting · Gout · principal investigator
- N/ANCT02787538 · Supporting Patient Care With Electronic Resources in the United StatesMassachusetts General Hospital · completed · Rheumatoid Arthritis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- SGLT2i As Novel Gout Care (SAVE-Care): A Randomized Controlled TrialR61AR084188 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2025 to 2026 · $219,637 awarded in 2026Grant number is on one of their registry trials
- Treat-to-Target Serum Urate versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial (TRUST)U01AR080985 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2023 to 2026 · $1,893,456 awarded in 2026Grant number is on one of their registry trials
- NOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUTR01AR065944 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2013 to 2025 · $639,196 awarded in 2025Same name and institution; not confirmed by an ID
- Planning for a Trial of Comparative Effectiveness of Gout Management StrategiesR34AR076077 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2020 to 2021 · $217,868 awarded in 2021Same name and institution; not confirmed by an ID
- The Risk and Risk Factors of Incident Hydroxychloroquine Retinopathy Among Long-Term UsersR21AR074754 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2019 to 2021 · $136,012 awarded in 2021Same name and institution; not confirmed by an ID
- Taskforce for the Generation of Evidence to Resolve the Gout Care Guideline Conflict (TOGETHER) ConferenceR13AR073116 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2017 · $22,000 awarded in 2017Same name and institution; not confirmed by an ID
- Methodologic Remedies for the Risk Factor Paradox in Osteoarthritis ProgressionR21AR068493 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2015 to 2016 · $102,006 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:22 UTC. The ranking covers the 200 most relevant of 54 PubMed records, and a shared surname and initials can bring in a namesake. All 54 on PubMed
- A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.Arthritis Rheum · 2002395 citationsRCR 11.7
- Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.Ann Rheum Dis · 2016202 citationsRCR 8.8
- 141 citationsRCR 5.4
- Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer.Br J Surg · 2003123 citationsRCR 3.8
- Randomized clinical trial comparing loop ileostomy and loop transverse colostomy for faecal diversion following total mesorectal excision.Br J Surg · 2002111 citationsRCR 3.5
- Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid.Arthritis Rheumatol · 201692 citationsRCR 4.0
- A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.Arthritis Rheum · 200091 citationsRCR 3.1
- An open-label, 6-month study of allopurinol safety in gout: The LASSO study.Semin Arthritis Rheum · 201584 citationsRCR 3.9
- Effects of Febuxostat in Early Gout: A Randomized, Double-Blind, Placebo-Controlled Study.Arthritis Rheumatol · 201782 citationsRCR 4.3
- 78 citationsRCR 3.4